Results 211 to 220 of about 19,908 (254)
Some of the next articles are maybe not open access.

Refractory Status Epilepticus

Journal of Palliative Medicine, 2004
A31-YEAR-OLD COMPUTER CONSULTANT was admitted to the hospital for intractable nausea and vomiting. He had presented 18 months earlier with a perforated bowel after a long history of Crohn’s disease. At surgical exploration he was found to have a perforated appendiceal cancer with omental and peritoneal metastases treated with a right hemicolectomy and ...
Mary, Golf   +5 more
openaire   +2 more sources

Refractory status epilepticus

Neurology, 1998
Mortality and morbidity associated with status epilepticus (SE) are, to a large extent, determined by the etiology underlying SE and the rapidity with which seizures are controlled.1 Most patients with SE will respond to aggressive treatment protocols that include repeated high doses of phenytoin, phenobarbital, and benzodiazepine.
R D, Sheth, B E, Gidal
openaire   +2 more sources

Status epilepticus: Refractory and super-refractory

Neurology India, 2017
Status epilepticus (SE) is an important neurological emergency. It is defined as seizures lasting for 5 minutes or more or recurrent seizures without recovery of consciousness to baseline between the attacks. Refractory SE (RSE) is defined as SE persisting despite sufficient dose of benzodiazepines and at least one antiepileptic drug (AED ...
Deepanshu, Dubey   +2 more
openaire   +2 more sources

Refractory status epilepticus

Neurology India, 2006
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance.
openaire   +2 more sources

Interferon-Associated Refractory Status Epilepticus

Pediatrics, 1994
Interferons have been used since the early 1980s for their antiviral, antiproliferative, and immunomodulatory actions to treat a variety of oncologic, infectious, and autoimmune disorders. Although many patients experience mild neurologic adverse effects with the administration of interferon, serious neurologic adverse effects are uncommon.1 We report ...
V S, Miller, R J, Zwiener, B A, Fielman
openaire   +2 more sources

Neuromodulation in Super-refractory Status Epilepticus

Journal of Clinical Neurophysiology, 2021
Summary: Status epilepticus (SE) is a severe condition that needs immediate pharmacological treatment to tackle brain damage and related side effects. In approximately 20% of cases, the standard treatment for SE does not control seizures, and the condition evolves to refractory SE.
Ioannis, Stavropoulos   +2 more
openaire   +2 more sources

VNS for refractory status epilepticus

Epilepsy Research, 2015
Our goal was to perform a systematic review of the literature on the insertion of vagal nerve stimulators (VNS) for refractory status epilepticus (RSE) and its impact on the control of RSE.All articles from MEDLINE, BIOSIS, EMBASE, Global Health, HealthStar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform, clinicaltrials ...
F.A. Zeiler   +4 more
openaire   +2 more sources

Hypothermia for Refractory Status Epilepticus

Neurocritical Care, 2008
Status epilepticus (SE) can be refractory to conventional anticonvulsants, requiring anesthetic doses of medications to suppress seizures. This approach carries significant morbidity, is associated with a high fatality rate, and may not always control SE.
Jesse J, Corry   +3 more
openaire   +2 more sources

Epilepsy, Status Epilepticus, and Refractory Status Epilepticus

2017
Epilepsy is a common nervous system disease that affects approximately 65 million people worldwide. Because it has diverse clinical manifestations, epilepsy is difficult to diagnose and treat. In contrast to epilepsy, status epilepticus (SE) is not self-terminating.
Yangmei Chen, Shichuo Li
openaire   +1 more source

Pentobarbital treatment of refractory status epilepticus

Neurology, 1987
We studied nine patients with status epilepticus refractory to standard therapy. In all patients so treated, IV pentobarbital terminated seizure activity. Mortality was high (77%) in those treated, but was attributed to underlying pathology and possibly to duration of status epilepticus.
M C, Rashkin, C, Youngs, P, Penovich
openaire   +2 more sources

Home - About - Disclaimer - Privacy